BioCentury | Feb 12, 2021
Finance

Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round

...RA Capital in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...Samsara BioCapital and Cormorant Asset Management. New investors include BlackRock, Janus Henderson Investors, Casdin Capital, Avidity Partners...
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...$175 million on Wednesday.Other investors in Nuvation’s PIPE include new investors 683 Capital, Ally Bridge, Avidity Partners...
BioCentury | Sep 15, 2020
Finance

Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more

...$73 million in a crossover round led by Wellington Management Company LLP. Additional new investors Avidity Partners...
BioCentury | Sep 5, 2020
Deals

Deal with AbbVie, PIPE triples I-Mab’s cash, positions biotech to be among China’s CD47 leaders

...June 30, I-Mab had $221.1 million in cash and restricted cash.Other investors in the PIPE included Avidity Partners...
BioCentury | Aug 19, 2020
Finance

Aug. 18 Quick Takes: Chinook fuels up for NASDAQ liftoff; plus Kymera, Poseida, Albireo

...New investors in the kidney disease company include EcoR1 Capital, OrbiMed Advisors, Rock Springs Capital, Avidity Partners...
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...Group, with participation from new investors Janus Henderson Investors, Fidelity, EcoR1 Capital, Hatteras Venture Partners, Avidity Partners...
BioCentury | Jun 5, 2020
Finance

With $85M series B, Athira seeks to recover neuronal health in Alzheimer’s patients

...Capital, Highside Capital Management, Logos Capital, funds managed by Janus Henderson Investors, Sofinnova Investments and Avidity Partners...
BioCentury | Feb 28, 2020
Finance

Verastem raises $100M, plots path forward with targeted cancer combo

...The syndicate included RA Capital, Vivo Capital, Venrock, Farallon Capital Management, Acuta Capital, EcoR1 Capital, Avidity Partners...
Items per page:
1 - 9 of 9
BioCentury | Feb 12, 2021
Finance

Public listing, Phase II cancer readouts in Cyteir’s sights as it banks $80M crossover round

...RA Capital in the round were Janus Henderson Investors, Acuta Capital Partners, Ally Bridge Group, Avidity Partners...
BioCentury | Dec 17, 2020
Finance

Dec. 16 Quick Takes: Neurogene raises $115M while BioAtla sees first-day pop; plus fundings for Atsena, MinervaX, Vivace, Arvinas

...Samsara BioCapital and Cormorant Asset Management. New investors include BlackRock, Janus Henderson Investors, Casdin Capital, Avidity Partners...
BioCentury | Oct 21, 2020
Deals

With roots in Medivation, Nuvation finds quick route to listing via year’s largest SPAC deal

...$175 million on Wednesday.Other investors in Nuvation’s PIPE include new investors 683 Capital, Ally Bridge, Avidity Partners...
BioCentury | Sep 15, 2020
Finance

Sept. 14 Quick Takes: $70M+ rounds for Escient, Escape, plus Alzheimer’s data lifts Cassava shares and more

...$73 million in a crossover round led by Wellington Management Company LLP. Additional new investors Avidity Partners...
BioCentury | Sep 5, 2020
Deals

Deal with AbbVie, PIPE triples I-Mab’s cash, positions biotech to be among China’s CD47 leaders

...June 30, I-Mab had $221.1 million in cash and restricted cash.Other investors in the PIPE included Avidity Partners...
BioCentury | Aug 19, 2020
Finance

Aug. 18 Quick Takes: Chinook fuels up for NASDAQ liftoff; plus Kymera, Poseida, Albireo

...New investors in the kidney disease company include EcoR1 Capital, OrbiMed Advisors, Rock Springs Capital, Avidity Partners...
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...Group, with participation from new investors Janus Henderson Investors, Fidelity, EcoR1 Capital, Hatteras Venture Partners, Avidity Partners...
BioCentury | Jun 5, 2020
Finance

With $85M series B, Athira seeks to recover neuronal health in Alzheimer’s patients

...Capital, Highside Capital Management, Logos Capital, funds managed by Janus Henderson Investors, Sofinnova Investments and Avidity Partners...
BioCentury | Feb 28, 2020
Finance

Verastem raises $100M, plots path forward with targeted cancer combo

...The syndicate included RA Capital, Vivo Capital, Venrock, Farallon Capital Management, Acuta Capital, EcoR1 Capital, Avidity Partners...
Items per page:
1 - 9 of 9